Quantum dots trigger immunomodulation of the NFκB pathway in human skin cells

Molecular Immunology

Volumn 48, Issue 12-13, 2011, Pages 1349-1359

  Romoser, Amelia A ^a   Chen, Patricia L ^b   Berg, J Michael ^a   Seabury, Christopher ^b   Ivanov, Ivan ^a,b   Criscitiello Michael F , M F ^b   Sayes, Christie M ^a,b,c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Texas A M University   (United States)

Author keywords

Gene expression; Nanoparticles; NF B pathway; Protein expression; Quantum dots

Indexed keywords

CADMIUM SELENIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; NANOCRYSTAL; PROTEIN; PROTEIN HMOX1; QUANTUM DOT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZINC SULFIDE;

ARTICLE; CELL DENSITY; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; GENE CONTROL; HUMAN; HUMAN CELL; IMMUNOMODULATION; KERATINOCYTE; PRIORITY JOURNAL; SKIN FIBROBLAST;

APOPTOSIS; CADMIUM COMPOUNDS; CELL DEATH; CYTOKINES; FIBROBLASTS; GENE EXPRESSION; HEME OXYGENASE-1; HUMANS; IMMUNOMODULATION; INFLAMMATION; KERATINOCYTES; METALS; NF-KAPPA B; POLYMERASE CHAIN REACTION; QUANTUM DOTS; REACTIVE OXYGEN SPECIES; SELENIUM COMPOUNDS; SKIN; SULFIDES; ZINC COMPOUNDS;

EID: 79957823425     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.02.009     Document Type: Article

References (61)

1. Alivisatos A.P., Gu W., Larabell C. Quantum dots as cellular probes. Annu. Rev. Biomed. Eng. 2005, 7:55-76.
2. Azzazy H.M.E., Mansour M.M.H., Kazmierczak S.C. From diagnostics to therapy: prospects of quantum dots. Clin. Biochem. 2007, 40:917-927.
3. Beg A.A., Baltimore D. An essetial role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 1996, 274:782-784.
4. Ceretti D., et al. Molecular cloning of the interleukin-1 converting enzyme. Science 1992, 256:97-99.
5. Damiano J.S., Oliveira V., Welsh K., Reed J.C. Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses. Biochem. J. 2004, 381:213-219.
6. Delehanty J.B., Medintz I.L., Pons T., Brunel F.M., Dawson P.E., Mattoussi H. Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjug. Chem. 2006, 17:920-927.
7. Delehanty J.B., Mattoussi H., Medintz I.L., Mattoussi H., Clapp A.R. Delivering quantum dots into cells: strategies, progress and remaining issues. Anal. Bioanal. Chem. 2008, (ePub ahead of print).
8. Derfus A.M., Chan W.C.W., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett. 2004, 4:11-18.
9. Duan H., Nie S. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J. Am. Chem. Soc. 2007, 129:3333-3338.
10. Fantuzzi L., et al. Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages. Blood 2008, 111:3355-3363.
11. Gao X., Cui Y., Levenson R.M., Chung L.W.K., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22:969-976.
12. Graham B.S.G. The two faces of NFkappaB in cell survival responses. Cell Cycle 2005, 4:1342-1345.
13. Hild W.A., Breunig M., Goepferich A. Quantum dots - nano-sized probes for the exploration of cellular and intracellular targeting. Eur. J. Pharm. Biopharm. 2008, 68.
14. Hoshino A., Fujioka K., Oku T., Suga M., Sasaki Y.F., Ohta T., Yasuhara M., Suzuki K., Yamamoto K. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett. 2004, 4:2163-2169.
15. Hoshino A., Hanada S., Manabe N., Nakayama T., Yamamoto K. Immune response induced by fluorescent nanocrystal quantum dots in vitro and in vivo. IEEE Trans. Nanobiosci. 2009, 8:51-57.
16. Huang C.C., Aronstam R.S., Chen D.R., Huang Y.W. Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles. Toxicol. In Vitro 2010, 24:45-55.
17. Huber M., Kraut N., Addicks T., Peter R.U. Cell-type-dependent induction of eotaxin and CCR3 by ionizing radiation. Biochem. Biophys. Res. Commun. 2000, 269:546-552.
18. Jaiswal J.K., Mattoussi H., Mauro J.M., Simon S.M. Longterm multiple color imaging of live cells using quantum dot bioconjugate. Nat. Nanotechnol. 2003, 21:47-51.
19. Jamieson T., Bakhshi R., Petrova D., Pocock R., Imani M., Seifalian A.M. Biological applications of quantum dots. Biomaterials 2007, 28:4717-4732.
20. Kamohara H.W.M., Shimozato O., Abe K., Galligan C., Hashimoto S., Matsushima K., Yoshimura T. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils. Immunology 2004, 111:186-194.
21. Kirchner C., Liedl T., Kudera S., Pellegrino T., Javier A.M., Gaub H.E., Stolzle S., Fertig N., Parak W.J. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 2005, 5:331-338.
22. Kopf M., et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994, 368:339-342.
23. Le J., Weinstein D., Gubler U., Vilcek J. Induction of membrane associated interleukin-1 by tumor necrosis factor in human fibroblasts. J. Immunol. 1987, 138:2137-2142.
24. Li Z.B., Cai W., Chen X. Semiconductor quantum dots for in vivo imaging. J. Nanosci. Nanotechnol. 2007, 7:2567-2581.
25. Liu Z.G., Hsu H., Goeddel D.V., Karin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis whil NF-kappaB activation prevents cell death. Cell 1996, 87:565-576.
26. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDCT method. Methods 2001, 25:402-408.
27. Livolsi A.V.B., Imbert V., Abraham R.T., Peyron J.F. Tyrosine phosphorylation-dependent activation of NF-κB. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur. J. Biochem. 2001, 268:1508-1515.
28. Maynard A.D., Kuempel E.D. Airborne nanostructured particles and occupational health. J. Nanopart. Res. 2005, 7:587-614.
29. McFarland-Mancini M., et al. Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J. Immunol. 2010, 184:7219-7228.
30. Medintz I.L., Mattoussi H., Clapp A.R. Potential clinical applications of quantum dots. Int. J. Nanomed. 2008, 3:151.
31. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-544.
32. Miura M., et al. Induction of apoptosis in fibroblasts by IL-1-beta-converting enzyme, a mammalian homolog of the c-elegans cell-death gene ced-3. Cell 1993, 75:653-660.
33. Monteiller C., Tran L., MacNee W., Faux S., Jones A., Miller B., Donaldson K. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 2007, 64:609-615.
34. Mortensen L., Oberdorster G., Pentland A.P., DeLouise L.A. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett. 2008, 8:2779-2787.
35. Murphree L., Sullivan G.W., Marshall M.A., Linden J. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kB in A2A adenosine receptor induction. Biochem. J. 2005, 391:575-580.
36. Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Int. Med. 2010, 267:89-105.
37. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
38. Ohta A., Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001, 414:916-920.
39. Prasad B.R., Nikolskaya N., Connolly D., Smith T.J., Byrne S.J., Gerard V.A., Gun'ko Y.K., Rochev Y. Long-term exposure of CdTe quantum dots on PC12 cellular activity and the determination of optimum non-toxic concentrations for biological use. J. Nanobiotechnol. 2010, 8:7.
40. Ramage L., Proudfoot L., Guy K. Expression of C-reactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles. Inhal. Toxicol. 2004, 16:607-613.
41. Rehberg M., Praetner M., Leite C.F., Reichel C.A., Bihari P., Mildner K., Duhr S., Zeuschner D.a.F.K. Quantum dots modulate leukocyte adhesion and transmigration depending on their surface modification. Nano Lett. 2010, 10:3656-3664.
42. Roco M.C. Broader societal issues of nanotechnology. J. Nanopart. Res. 2003, 5:181-189.
43. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Variables influencing interactions of untargeted quantum dot nanoparticles with skin cells and identification of biochemical modulators. Nano Lett. 2007, 7:1344-1348.
44. Rzigalinski B., Strobl J.S. Cadmium-containing nanoparticles: perspectives on pharmacology & toxicology of quantum dots. Toxicol. Appl. Pharmacol. 2009, 238:280-288.
45. Sanjiv D., Sharma A.K., Arora R.C., Slezak J., Singal P.K. IL-10 attenuates TNF-a-induced NFκB pathway activation and cardiomyocyte apoptosis. Cardiovasc. Res. 2009, 82:59-66.
46. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
47. Su Y., He Y., Lu H., Sai L., Li Q., Li W., Wang L., Shen P., Huang Q., Fan C. The cytotoxicity of cadmium based, aqueous phase - synthesized, quantum dots and its modulation by surface coating. Biomaterials 2009, 30:19-25.
48. Tang M., Xing T., Zeng J., Wang H., Li C., Yin S., Yan D., Deng H., Liu J., Wang M., Chen J., Ruan D.Y. Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons. Environ. Health Perspect. 2008, 116:915-922.
49. Trincavelli M.L., Falleni A., Chelli B., Tuscano D., Costa B., Gremigni V., Lucacchini A., Martini C. A(2A) adenosine receptor ligands and proinflammatory cytokines induce PC 12 cell death through apoptosis. Biochem. Pharmacol. 2003, 66:1953-1962.
50. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789.
51. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:1-11.
52. Waetzig G., Rosenstiel P., Arlt A., Till A., Bräutigam K., Schäfer H., Rose-John S., Seegert D., Schreiber S. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-β1. FASEB 2004, 19:91-93.
53. Walling M.A., Novak J.A., Shepard J.R.E. Quantum dots for live cell and in vivo imaging. Int. J. Mol. Sci. 2009, 10:441-491.
54. Wang C., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274:784-787.
55. Wijayanti N.S.H., Samoylenko A., Kietzmann T., Immenschuh S. Role of NF-kappaB and p38 MAP kinase signaling pathways in the lipopolysaccharide-dependent activation of heme oxygenase-1 gene expression. Antioxid. Redox Signal. 2004, 6:802-810.
56. Wolter S., et al. C-jun controls histone modifications, NF-kB recruitment, and RNA polymerase II function to activate the ccl2 gene. Mol. Cell. Biol. 2008, 28:4407-4423.
57. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 1999, 103:129-135.
58. Zandi E. The IkB kinase complex (IKK) contains two kinase subunits, IKKa and IKKb, necessary for IkB phosphorylation and NFκB activation. Cell 1997, 91:243-252.
59. Zhang L.W., Monteiro-Riviere N.A. Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin. Skin Pharmacol. Physiol. 2008, 21:166-180.
60. Zhang L.W., Monteiro-Riviere N.A. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol. Sci. 2009, 110:138-155.
61. Zhang T., Stilwell J.L., Gerion D., Ding L., Elboudwarej O., Cooke P.A., Gray J.W., Alivisatos A.P., Chen F.F. Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. Nano Lett. 2006, 6:800-808.